Fully-continuous, automated bioprocessing is achievable only when processes are tightly integrated and engineered to eliminate volume mismatches between steps and digitally managed to ensure system-wide visibility and interventions. The post Interface Mismatches Remain Key Barrier to Continuous Bioprocessing appeared first on GEN – Genetic Engineering and Biotechnology News.
You may also like
EC approves Erbitux combination for first‑line...
FDA approves Leqembi Iqlik subcutaneous initiation...
AstraZeneca agrees on $1.5bn deal with Dizal...
Cherry appoints Peter Henshaw as new Managing Director
FDA Issues Proposal to Streamline Registration for...
Cellares and Sonoma Biotherapeutics Agree to Automate...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.